Today’s volatile political environment is creating uncertainty and worry that can disrupt sleep and may even lead to a sleep ...

Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today ...

Daridorexant, a dual orexin receptor antagonist, is currently approved for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

Current obstructive sleep apnea (OSA) diagnosis methods, although often effective, all require the patient to be asleep ...

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy across both insomnia- and nocturia-related endpoints in a placebo-controlled study in patients with chronic ...

Among patients with OSA, sleep surgery vs CPAP therapy or no treatment reduces the risk for motor vehicle accidents.

Fragmented sleep is associated with the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD).

Among patients with obstructive sleep apnea using CPAP, pitolisant given at 20 mg and 40 mg reduces excessive daytime sleepiness.

Many hospitals are not adequately informing patients about charity care policies required by the Affordable Care Act, leading to significant medical debt issues. Tamara Robinson's experience with a ...